The past 15 years have witnessed an explosion in the drugs market for multiple sclerosis (MS), enabling the first disease modifying therapies in the neurodegenerative disease market to become a...
2 October 2017
29 September 2017
Artificial intelligence (AI) is being implemented in almost every aspect of day-to-day life. From recommendations on Netflix or Spotify and fraud detection for your bank account, to experimental self-driving cars,...
28 September 2017
This month, Merck’s Mavenclad (cladribine) become available in the UK to treat highly active relapsing multiple sclerosis (MS). Mavenclad is the first high efficacy, infrequent dosing oral agent approved for...
21 September 2017
Once hailed as the next great thing in female sterilization, Bayer’s Essure device will no longer be sold outside of the US, the company announced on Monday.
30 August 2017
While covering an expansive number of cardiovascular (CV) indications, this year’s European Society of Cardiology (ESC) Conference in Barcelona had a particular focus on digital health.
24 August 2017
Following a move to fix price ceilings for coronary stent products, India’s National Pharmaceutical Pricing Authority (NPPA) has announced a plan to cap the pricing of orthopedic knee replacement implants.
22 August 2017
In July 2017, Pentax Medical and Shanghai AoHua Photoelectricity formed a joint venture (JV) company to develop products in the field of flexible medical endoscopy.
15 August 2017
On 7 August, Fresenius Medical Care (Fresenius) announced its acquisition of NxStage Medical (NxStage) for $2bn.
10 August 2017
With the fast development of IBM’s Watson and Google’s DeepMind, artificial intelligence (AI) is one of the key terms in 2017. GlobalData believes that AI will inevitably be used in...
31 July 2017
Amazon is headed towards a new venture in health technology. CNBC reported that the company has a healthcare team that is focused on virtual doctor visits and health apps.